The landscape of American healthcare in 2026 continues to be defined by a widening gap between the cost of medical services and the average consumer’s ability to pay, a trend that has forced a significant portion of the population to forego essential care. According to recent data from KFF, the financial strain of healthcare has reached a critical juncture, with 75% of uninsured adults in the United States reporting that they skipped or postponed necessary medical interventions in 2025 due to prohibitive costs. This crisis of affordability is not limited to those without insurance; even among the insured, approximately half of U.S. adults report difficulty affording their healthcare expenses, while 30% of households struggled to pay medical bills within the past twelve months. As these financial pressures mount, the role of the employer in providing a robust and flexible benefits package has shifted from a secondary perk to a primary economic necessity.
The Growing Burden of Out-of-Pocket Expenses
Out-of-pocket costs are defined as the portion of medical expenses that health insurance plans do not cover, requiring the policyholder to pay the provider directly. These expenses encompass a wide array of charges, including deductibles—the amount a patient must pay before their insurance begins to cover costs—as well as copayments and coinsurance for doctor visits, emergency room care, and surgical procedures. Furthermore, many individuals face significant costs for services or items not covered by their specific plan, such as certain prescription medications, specialized therapies, or out-of-network care.
For the 2026 plan year, the Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) have set the maximum out-of-pocket limits at $10,600 for an individual policy and $21,200 for a family policy. These figures represent the upper limit of what a consumer would have to pay for in-network essential health benefits in a year. However, for many middle- and low-income families, even reaching a fraction of these limits can result in significant debt or the depletion of personal savings. This reality has placed a spotlight on employer-sponsored reimbursement models as a vital tool for financial stability.
A Chronology of Reimbursement Evolution
The transition toward the current reimbursement-centric model of employee benefits did not happen overnight. It is the result of over a decade of legislative changes and shifting market dynamics aimed at providing more flexibility to both employers and employees.
- 2010: The Affordable Care Act (ACA): The ACA established the foundation for modern health benefits, introducing the employer mandate for large organizations and defining essential health benefits. However, it also led to a rise in high-deductible health plans (HDHPs) as employers sought to manage soaring premium costs.
- 2016: The 21st Century Cures Act: This legislation introduced the Qualified Small Employer Health Reimbursement Arrangement (QSEHRA). For the first time, small businesses (those with fewer than 50 full-time employees) could reimburse their staff for individual health insurance premiums and out-of-pocket costs tax-free, without needing to offer a group health plan.
- 2020: The Expansion of HRAs: New federal regulations took effect, creating the Individual Coverage Health Reimbursement Arrangement (ICHRA) and the Excepted Benefit HRA (EBHRA). The ICHRA, in particular, revolutionized the market by allowing employers of any size to move away from traditional group plans entirely, instead providing employees with tax-free funds to purchase their own coverage on the open market.
- 2023–2025: Post-Pandemic Inflationary Pressures: Following the global pandemic, medical inflation surged. Employers began to see double-digit increases in group plan premiums, leading many to seek more predictable, "defined contribution" models like HRAs to cap their healthcare spending while still supporting their workforce.
- 2026: The Current State: As of mid-2026, HRAs have become a mainstream alternative to traditional insurance, favored for their ability to provide personalized benefits in a high-cost environment.
Understanding Reimbursable Health Expenses Under IRS Guidelines
To effectively leverage reimbursement benefits, employers must navigate the complexities of IRS Publication 502. This document outlines more than 200 types of medical and dental expenses that are eligible for reimbursement through tax-advantaged accounts like Health Reimbursement Arrangements (HRAs), Health Savings Accounts (HSAs), and Flexible Spending Accounts (FSAs).
Eligible expenses under IRS Section 213(d) are broad, covering not just physician services but also preventive care and long-term management tools. Common reimbursable items include:
- Prescription medications and certain over-the-counter drugs.
- Diagnostic devices, such as blood sugar test kits for diabetics.
- Mental health services, including therapy and psychiatric care.
- Vision care, including contact lenses, eyeglasses, and laser eye surgery.
- Dental treatments, including cleanings, X-rays, and orthodontic work.
- Medical equipment like crutches, wheelchairs, and hearing aids.
For employees managing chronic conditions—such as heart disease, asthma, or diabetes—these reimbursements are transformative. Ongoing care and specialist visits can quickly exhaust a household budget, but when these costs are covered by employer contributions through an HRA, the financial barrier to adherence is significantly lowered.
Strategic Implementation: HRAs versus Health Stipends
Employers looking to alleviate the burden of out-of-pocket costs generally choose between two primary mechanisms: formal Health Reimbursement Arrangements (HRAs) or informal health stipends. Each has distinct regulatory and tax implications.
The HRA Advantage
HRAs are employer-funded, tax-advantaged accounts. Because they are formal group health plans under the law, the reimbursements are 100% tax-free for both the employer (as a business deduction) and the employee (as excluded income). There are three primary types currently dominating the market:
- Qualified Small Employer HRA (QSEHRA): Designed for small businesses, allowing them to reimburse for premiums and medical bills up to an annual limit set by the IRS.
- Individual Coverage HRA (ICHRA): A flexible option for businesses of any size that allows for different reimbursement amounts based on employee classes (e.g., full-time vs. part-time).
- Group Coverage HRA (Integrated HRA): This is paired with a traditional group health plan to help employees cover the high deductibles associated with the plan.
The Role of Health Stipends
For organizations seeking a simpler, less regulated approach, health stipends offer an alternative. A stipend is a fixed sum provided to employees to help with medical costs. However, unlike HRAs, stipends are considered taxable income. Employees must pay income tax on the funds, and employers must pay payroll taxes. Furthermore, stipends do not satisfy the ACA’s employer mandate for organizations with 50 or more full-time equivalent employees, making them more suitable for very small startups or as a secondary "wellness" perk rather than a primary health benefit.
Expert Analysis and Market Implications
Industry analysts suggest that the shift toward reimbursement models reflects a broader move toward "personalization" in the workplace. Traditional group plans often operate on a "one size fits all" basis, which can lead to inefficiencies where young, healthy employees pay for coverage they don’t use, while older employees or those with families find the coverage insufficient.
"The data from 2025 and 2026 shows a clear correlation between the rising cost of care and employee turnover," says Michael Roberts, a senior healthcare benefits consultant. "When an employee is hit with a $5,000 unexpected medical bill, they don’t just look for a better doctor; they look for a better job. Employers who use HRAs to cap those out-of-pocket risks are seeing higher retention rates and improved morale."
From a fiscal perspective, HRAs allow companies to move from a "defined benefit" model (where the company’s costs fluctuate based on the insurance carrier’s annual rate hikes) to a "defined contribution" model (where the company decides exactly how much it can afford to spend per employee). This predictability is vital for long-term financial planning in an uncertain economy.
Broader Impact on Public Health and Productivity
The implications of medical cost reimbursement extend beyond the corporate balance sheet and into the realm of public health. When 75% of uninsured adults skip care, the result is often the progression of treatable conditions into emergency situations. This "delayed care" cycle increases the overall cost of the American healthcare system by shifting care from low-cost preventive settings to high-cost emergency rooms.
By providing funds for out-of-pocket expenses, employers are essentially subsidizing preventive care. Employees who can afford their copayments are more likely to attend annual physicals, manage their blood pressure, and seek early intervention for illness. This leads to a healthier, more productive workforce with lower rates of absenteeism.
As we move through 2026, the integration of technology-driven platforms like PeopleKeep and Remodel Health has made the administration of these complex HRA programs accessible to small and mid-sized enterprises. These platforms automate the verification of receipts and ensure compliance with ever-changing IRS regulations, removing the administrative hurdle that previously prevented smaller firms from offering sophisticated benefits.
Conclusion
The escalating cost of medical care in the United States has necessitated a reinvention of the employer-employee social contract regarding health benefits. With out-of-pocket maximums reaching new heights and the majority of uninsured Americans skipping essential care, the traditional insurance model is being supplemented—and in some cases replaced—by flexible reimbursement frameworks. Whether through the tax-advantaged structure of an HRA or the simplicity of a health stipend, providing direct financial support for medical expenses is no longer just a benefit; it is a strategic imperative for any organization looking to maintain a healthy and loyal workforce in the modern economy.
